US 6,967,208 · Application 10/245,122 · Granted Nov 22, 2005
US 6,967,208
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
Estimated expiration
February 3, 2023
Expired 1337 days ago
Earliest effective filing
Sep 17, 2002
+ 20 years
Sep 17, 2022
PTA +139d
Feb 3, 2023
TD cap (US 7,338,963)
Apr 8, 2023
Final
Feb 3, 2023
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- September 17, 2002
- Earliest effective filing
- September 17, 2002
- Issue date
- November 22, 2005
- PTA
- +139 days
- Base expiry (before PTA)
- September 17, 2022
September 17, 2002 + 20 years = September 17, 2022 + 139 PTA days = February 3, 2023
- PRO60/324,165 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to April 8, 2023 (earliest expiring referenced patent: US 7,338,963)
US 3,822,000
Could not resolve calculation details
US 10,245,122· Application 15/643,634Capping patent
Method and device for causing tooth movement
- Filing date
- Jul 7, 2017
- Earliest effective filing
- May 14, 2012
- Issue date
- Apr 2, 2019
- PTA
- 0 days
- Calculated expiration
- May 14, 2032
Continuation of 15/208,401, filed Jul 12, 2016, issued as US 9,814,547
Continuation of 14/326,069, filed Jul 8, 2014, issued as US 9,387,051
Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969
Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777
Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777
Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969
Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777
Continuation of 14/326,069, filed Jul 8, 2014, issued as US 9,387,051
Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969
Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777
May 14, 2012 + 20y = May 14, 2032
US 8,188,120· Application 13/101,536Lapsed
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
Expired: maintenance fee lapse.
- Filing date
- May 5, 2011
- Earliest effective filing
- May 5, 2011
- Issue date
- May 29, 2012
- PTA
- 0 days
- Calculated expiration
- —
US 8,470,854· Application 13/444,999Lapsed
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
Expired: maintenance fee lapse.
- Filing date
- Apr 12, 2012
- Earliest effective filing
- Apr 12, 2012
- Issue date
- Jun 25, 2013
- PTA
- 0 days
- Calculated expiration
- —
US 7,338,963· Application 11/198,801Capping patent
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
- Filing date
- Aug 5, 2005
- Earliest effective filing
- Sep 17, 2002
- Issue date
- Mar 4, 2008
- PTA
- +203 days
- Calculated expiration
- Apr 8, 2023
Divisional of 10/850,587, filed May 20, 2004, issued as US 6,989,391
Divisional of 10/245,122, filed Sep 17, 2002, issued as US 6,967,208
Divisional of 10/245,122, filed Sep 17, 2002, issued as US 6,967,208
Sep 17, 2002 + 20y + 203d PTA = Apr 8, 2023
Notes (1)
- [TD_DOCS_TRUNCATED] Found 12 filed TD documents; parsing first 3 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 10/245,122 · US 6,967,208
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 6,967,208: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US6967208Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.